NCT06248463

Brief Summary

The goal of this observational study is to compare in healthy pregnant women during the first trimester. The main question it aims to answer are: Accuracy of measuring automatically Blood Pressure (BP) at appointment compared to 24 Hour Ambulatory Blood Pressure Monitor (ABPM). Participants will be BP measured with homologated device every 3 minutes in waiting room for 20 minutes. Researchers will compare Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) in clinical visit to see if are comparable to ABPM.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
659

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Nov 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Nov 2024Jul 2026

First Submitted

Initial submission to the registry

January 31, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

February 12, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

January 31, 2024

Last Update Submit

February 8, 2024

Conditions

Keywords

Hypertension in pregnancy.Blood Pressure measurement.

Outcome Measures

Primary Outcomes (3)

  • Differences in Blood Pressure between office and 24- Ambulatory Blood Pressure Meassurement (24-h ABPM)

    Concordance of Systolic and Diastolic Blood Pressure mean between waiting room and 24-h ABMP measurements

    10 mounths

  • Maternal

    Cardiovascular events, preeclampsia, abruptio, cesarean delivery, hemorrhage,pulmonary edema, death

    10 months

  • Newborn

    Growth restriction, preterm delivery, congenital anomalies, stillbirth, neonatal death.

    10 monts

Study Arms (1)

Woman with hypertension risk related to gestation

SBP readings above 130 mmHg in office or the presence of a risk factor for eclampsia: (hypertensive disease in previous pregnancy, chronic hypertension, chronic renal disease, diabetes mellitus, or autoimmune disease) or any two moderate-risk factors (nulliparity, age ≥40 years, BMI ≥35 kg/m2, family history of PE, or interpregnancy interval \>10 years)

Diagnostic Test: BP measurement in waiting room for 20 minutes

Interventions

Measured of BP will be performance in waiting room for 20 minutes every 3 minutes and report by an mobile app. After 24h-ABPM device will be implanted. Results of SBP and DBP obtained in office will be compared with 24-h, diurnal and nocturnal SBP/DBP mean. BP will be measured automatically and repeatedly every 3 minutes in the waiting room for 20 minutes. Subsequently, a SpaceLab ABPM monitor will be implanted.

Also known as: ABPM-24 h
Woman with hypertension risk related to gestation

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsGestation
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women with suspected hypertension

You may qualify if:

  • Woman during the first 12 weeks of pregnancy Maternal age\>35 Nulliparity Previous history of hypertension Short and long interpregnancy interval Use of assisted reproductive technologies Family history of preeclampsia Obesity. BMI\>30. Hyperglycemia Renal disease

You may not qualify if:

  • Any inability to perform 24-h ambulatory BP measurement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypertensionHypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

JUAN F SANCHEZ MUÑOZ-TORRERO, MD

CONTACT

JONHATAN GOMEZ RAJA, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
10 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 8, 2024

Study Start

November 1, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

February 12, 2024

Record last verified: 2024-01